4//SEC Filing
Benaim Ely 4
Accession 0001645113-21-000069
CIK 0001645113other
Filed
May 27, 8:00 PM ET
Accepted
May 28, 4:36 PM ET
Size
8.2 KB
Accession
0001645113-21-000069
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Benaim Ely
Chief Medical Officer
Transactions
- Exercise/Conversion
Options to Buy Ordinary Shares
2021-05-27−1,833→ 7,332 totalExercise: $47.56Exp: 2029-05-07→ Ordinary Shares (1,833 underlying) - Exercise/Conversion
Ordinary Shares
2021-05-27$47.56/sh+1,833$87,177→ 30,887 total - Sale
Ordinary Shares
2021-05-27$200.00/sh−1,833$366,600→ 29,054 total
Footnotes (2)
- [F1]Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim.
- [F2]Fully vested as of the date hereof.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001632237
Filing Metadata
- Form type
- 4
- Filed
- May 27, 8:00 PM ET
- Accepted
- May 28, 4:36 PM ET
- Size
- 8.2 KB